There are already exemplars: in the case of Parkinson’s, loss of SCFA producers years prior to the first symptom; in Alzheimer’s, bile acid ratios predicting tau protein dispersion; and in depression, low levels of anandamide predicting stress vulnerability. The gene discussed is MAPT; the disease is depressive symptom measurement.